Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study for the Validation of the Genetic Signature 354849 to Predict the Response to Standard Treatment in Patients With Locally Advanced Cervical Cancer

NCT04067882 is registered in ClinicalTrials.gov with National Institute of Cancerología as lead sponsor.

NCT NCT04067882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04067882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study for the Validation of the Genetic Signature 354849 to Predict the Response to Standard Treatment in Patients With Locally Advanced Cervical Cancer
Lead sponsor
National Institute of Cancerología
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2019
Completion date
May 30, 2024
Enrollment
189 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cervix cancer